2019
DOI: 10.1016/j.cnc.2018.11.008
|View full text |Cite
|
Sign up to set email alerts
|

Acute and Chronic Hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
2
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(4 citation statements)
references
References 17 publications
0
2
0
1
Order By: Relevance
“…Hipertensi dapat disebabkan oleh peningkatan kinerja jantung dalam memompa darah agar dapat memenuhi kebutuhan oksigen dan nutrisi tubuh. Hipertensi yang tidak segera ditangani dapat mengganggu kinerja organ lain seperti jantung dan ginjal (Kementerian Kesehatan RI, 2013;Rivera, 2019). Dari 2013 hingga 2018, prevalensi hipertensi di Indonesia terus mengalami peningkatan.…”
Section: Pendahuluanunclassified
“…Hipertensi dapat disebabkan oleh peningkatan kinerja jantung dalam memompa darah agar dapat memenuhi kebutuhan oksigen dan nutrisi tubuh. Hipertensi yang tidak segera ditangani dapat mengganggu kinerja organ lain seperti jantung dan ginjal (Kementerian Kesehatan RI, 2013;Rivera, 2019). Dari 2013 hingga 2018, prevalensi hipertensi di Indonesia terus mengalami peningkatan.…”
Section: Pendahuluanunclassified
“…Hypertension management depends on its severity and associated risks of developing other diseases. It includes pharmacological and nonpharmacological approaches such as modification of the lifestyle activities and exercises (Rivera et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…This helps explain why the majority of persons with HTN are undiagnosed and untreated (Whelton et al, 2018). Although blood pressure (BP) control has improved over the past 20 years, it remains a challenge for both patients and clinicians (Carter, 2018; Rivera et al, 2019) because only 50% will achieve and maintain BP control of <140/90 mm Hg (Tereshchenko et al, 2017). Poorly controlled HTN carries with it significant morbidity and can lead to end-organ damage, such as heart attack, heart failure, stroke, and kidney disease.…”
Section: Introductionmentioning
confidence: 99%
“…By 2030, experts estimate that the annual cost of HTN will approach 200 billion dollars (Kirkland et al, 2018). Evidence suggests that a combination of lifestyle modifications and pharmacologic interventions is the optimal treatment strategy (Rivera et al, 2019). However, ever-increasing clinician time constraints, breadth of treatment options, patient comorbidities, and educational needs may affect the ability to effectively provide comprehensive HTN care (Braam et al, 2017).…”
Section: Introductionmentioning
confidence: 99%